Vimarsana
Biggest News Aggregation in the World

Later Tool News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Later Tool. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Later Tool Today - Breaking & Trending Today

Patients With Neuroendocrine Tumors May Value QOL Over Survival - Vimarsana News

Patients With Neuroendocrine Tumors May Value QOL Over Survival

Many patients with advanced neuroendocrine tumors may value preserving their quality of life over extending their survival.

Independence Valued Over Survival for Neuroendocrine Tumor Patients - Vimarsana News

Independence Valued Over Survival for Neuroendocrine Tumor Patients

Independence is valued over survival among adult patients with neuroendocrine tumors (NETs).

Patients With Neuroendocrine Tumors May Value QOL Over Survival - Vimarsana News

Patients With Neuroendocrine Tumors May Value QOL Over Survival

Many patients with advanced neuroendocrine tumors may value preserving their quality of life over extending their survival.

Independence Valued Over Survival for Neuroendocrine Tumor Patients - Vimarsana News

Independence Valued Over Survival for Neuroendocrine Tumor Patients

FRIDAY, Dec. 30, 2022 (HealthDay News) -- Independence is valued over survival among adult patients with neuroendocrine tumors (NETs), according to a study published in the December issue of the Journal of the National Comprehensive Cancer Network. Daneng Li, M.D., from City of Hope in Duarte, California, and colleagues examined patient values toward treatment goals

Patients With Neuroendocrine Tumors May Value QOL Over Survival - Vimarsana News

Patients With Neuroendocrine Tumors May Value QOL Over Survival

Many patients with advanced neuroendocrine tumors may value preserving their quality of life over extending their survival.